Remove 2022 Remove Leads Remove Pharma
article thumbnail

10 noteworthy pharma leadership shake-ups this year

PharmaVoice

From GSK to Roche to Biogen, these were the most impactful executive changes at leading pharma companies in 2022.

Pharma 246
article thumbnail

Akero’s New MASH Drug Data: Longer Treatment Leads to More Liver Benefit

MedCity News

The latest Akero data build on six-month results reported in 2022. Akero Therapeutics’ preliminary Phase 2b data show that treatment with its MASH drug, efruxifermin, continued to distance itself from a placebo measured at nearly two years of treatment.

Leads 312
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The continued shame of pharma

World of DTC Marketing

Still, the pharma industry is fighting hard to keep it off the table. Yet, high drug prices lead to soaring out-of-pocket costs , dangerous drug rationing , and a depletion of limited financial resources —especially for those with fixed incomes. Pharma is a very profitable industry.

Pharma 256
article thumbnail

LTS Lohmann leads investment in needle-free delivery specialist

Fierce Pharma

LTS Lohmann leads investment in needle-free delivery specialist. Tue, 11/29/2022 - 10:21.

Leads 188
article thumbnail

Gilead’s $285M Confidence Vote for Next-Gen Cancer Med & New Cell Therapy Tech

MedCity News

Gilead Sciences is increasing its stake in partner Arcellx and expanding the cell therapy alliance the companies started in 2022. The deal expands the lead partnered program to more cancers and gives Gilead a chance at another Arcellx cell therapy candidate made with different technology.

Leads 306
article thumbnail

Erytech pivots to extracellular vesicle drug delivery after lead candidate collapses

Fierce Pharma

Erytech pivots to extracellular vesicle drug delivery after lead candidate collapses. Tue, 11/22/2022 - 08:53.

Leads 152
article thumbnail

Pharma running online ads on vaccine misinformation sites

World of DTC Marketing

Included in the programmatic ad errors is Pfizer, who developed a leading COVID vaccine. When will pharma stop using programmatic online ads? Again and again, I have seen robust fraud and online ads being placed on sites that pharma would normally block in their system. Programmatic has been a thorn in online advertisers.

Pharma 180